Plain-English translation of NCT03651349 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Taiwan
Sponsor
Everfront Biotech Co., Ltd.
Enrollment target
~56 participants
Started
February 2021
Primary completion
December 2027
Age range
20 Years and older
Last updated on clinicaltrials.gov in September 2026.